Table 4.
Peptides |
HLA molecule |
|||||||
---|---|---|---|---|---|---|---|---|
Position | Sequence | A1/B18 | A2 | A3/11 | A24 | B7/35/51 | B27 | B44 |
15–22 | RPRKLPQL | 10−9 | ||||||
18–26 | KLPQLCTEL | 10−4 | ||||||
19–26 | LPQLCTEL | 10−5 | ||||||
21–30 | QLCTELQTTI | 10−5 | ||||||
24–33 | TELQTTIHDI | 10−5 | ||||||
26–34 | LQTTIHDII | 10−5 | ||||||
46–55 | RREVYDFAFR | 10−7 | ||||||
49–57 | VYDFAFRDL | 10−9 | ||||||
50–57 | YDFAFRDL | 10−6 | ||||||
52–60 | FAFRDLCIV | 10−4 | 10−6 | |||||
54–61 | FRDLCIVY | 10−4 | 10−4 | 10−4 | ||||
59–67 | IVYRDGNPY | 10−6 |
Binding capacities of peptides to immunopurified HLA class I molecules are expressed in M and have been evaluated from at least three independent experiments.